Buscar
Mostrando ítems 11-20 de 48
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials
(AIDS reviews, 2021)
COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment ...
Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation
(Transplantation proceedings, 2021)
Background
Frequent and rapid development of myelopathy has been reported in individuals with human T-lymphotropic virus type 1 (HTLV-1) infection following solid organ transplantation. There is no information regarding ...
Why such excess of mortality for COVID-19 in Spain?
(Therapeutic Advances in Infectious Disease, 2020-06)
The current global crisis produced by the SARS-CoV-2 pandemic is unprecedented. Even the 1918 influenza pandemic (Spanish flu) did not halt the planet so abruptly and deeply as it ran during World War I.
Rapid antigen Testing and Mask Wearing While Waiting for COVID-19 Vaccines
(AIDS reviews, 2020)
After the rapid surge of COVID-19 in Europe during the spring of 2020, implementation of lockdowns succeeded in drastically reduce the number of cases and deaths within 2-3 months. However, it came at a heavy socioeconomic ...
Tough requirements for new antiretroviral drugs
(The Lancet HIV, 2020-03)
Medical and social attention to HIV infection has declined globally and is increasingly focused on developing regions, where the epidemic is still largely uncontrolled. In North America and western Europe, AIDS is rarely ...
Keeping alive enterprises while embracing unprecedented COVID-19 restrictions
(Therapeutic Advances in Infectious Disease, 2020-04)
COVID-19 is rapidly expanding globally, with more than 1,800,000 cases and 105,000 deaths to date (April 11, 2020) (www.worldometers.info). The WHO upgrade to pandemic, the emergency declaration in the United States, and ...
Advances in hepatitis B therapeutics
(Therapeutic Advances in Infectious Disease, 2020-10)
Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million people are chronically infected with the hepatitis B virus (HBV). Globally, chronic hepatitis B is the leading cause of ...
Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach
(SAGE Publications Inc., 2021)
Fifty-four consecutive persons with HIV co-infected with hepatitis C virus (HCV) and liver decompensation were treated with direct-acting antivirals (DAA). The HCV treatment was delivered using a multidisciplinary ...
Hepatitis delta in patients hospitalized in Spain (1997-2018)
(NLM (Medline), 2021)
BACKGROUND: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the ...
Overt and occult hepatitis B among immigrants and native blood donors in Madrid, Spain
(Therapeutic Advances in Infectious Disease, 2020-12)
Background:
The risk of transfusion-transmitted viral infections is very low in developed countries. Recent massive migration flows from highly hepatitis B virus (HBV), hepatitis C virus (HCV) and/or HIV endemic regions ...